Renal tolerability of teicoplanin in a case of neonatal overdose

Journal of Chemotherapy

Volumn 10, Issue 5, 1998, Pages 381-384

  Fanos, V ^a   Mussap, M ^b   Khoory, B J ^a   Vecchini, S ^a   Plebani, M ^b,c   Benini, D ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Center for Biomedical Research   (Italy)

Author keywords

Kidney; Newborn; Overdose; Safety; Teicoplanin

Indexed keywords

AMPICILLIN; CREATININE; CYSTATIN C; EPIDERMAL GROWTH FACTOR; METICILLIN; NITROGEN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; FETUS DISTRESS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROTOXICITY; NEWBORN; NEWBORN CARE; SEPSIS; STAPHYLOCOCCUS; URINALYSIS;

EID: 0031795003     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.5.381     Document Type: Article

References (14)

1. Gaynes RP, Edwards JR, Jarvis WR. et al. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996 Sep; 98 (3): 357-361.
2. Fanos V, Verlato G, Dal Moro A. et al. Staphylococcus epidermidis isolation and antibiotic resistance in a neonatal intensive care unit. J Chemother 1995; 7 (1): 26-29.
3. Saez-Llorens X, McCracken GH. Clinical pharmacology of antibacterial agents. In: Remington JS, Klein JO, editors. Infectious disease of the fetus, newborn and infants. Philadelphia: Saunders, 1995: 1287-1336.
4. Wallace MR, Mascola JR, Oldfield EC III. Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 1991; 164: 1180-1185.
5. Chow AW, Azar RW. Glycopeptides and nephrotoxicity. Intensive Care Med 1994; 20: 523-529.
6. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-222.
7. Fanos V, Kacet N, Mosconi G. A review of teicoplanin in the treatment of serious neonatal infections. Eur J Pediatr 1997; 156: 423-427.
8. Mussap M, Fanos V, Ruzzante N, et al. Urinary N-acetyl-β-D-glucosaminidase (NAG) and alpha 1 microglobulin excretion as an index of renal tubular dysfunction in the neonate. Eur J Lab Med 1997; 5 (3): 1-4.
9. Fanos V, Padovani EM. Importance of evaluation of urinary enzymes and microglobulins in the neonatal period [in Italian] Ital J Ped 1995; 6: 775-783.
10. Fanos V, Mussap M, Verlato G, et al. Evaluation of antibiotic-induced nephrotoxicity in preterm newborns by determining urinary alpha-1 microglobulin. Pediatr Nephrol 1996; 10: 645-647.
11. Cuzzolin L, Fanos V, Zambreri D, et al. Pharmacokinetics and renal tolerance of aztreonam in premature infants. Antimicrob Agents Chemother 1991; 35: 1726-1728.
12. Plebani M, Fanos V, Mussap M, et al. Urinary excretion of human Epidermal Growth Factor (hEGF) in premature infants requiring assisted ventilation over the first week of life. Nephron 1997; 76: 225-226.
13. Mussap M, Plebani M, Fanos V, et al. Serum cystatin C in healthy full-term newborns: preliminary reference values for a promising endogenous marker of glomerular filtration rate. Prenat Neonat Med 1997, 2: 1-5.
14. Mussap M, Fanos V. New applications of urinary biomarkers in neonatal and pediatric nephrology. Proceedings of the 8th International Workshop of Neonatal Nephrology. II Pediatra 1998: XX (8) 47-48.